Announced
Completed
Financials
Sources
Tags
Private
Private Equity
Friendly
Domestic
Minority
Single Bidder
Acquisition
United Kingdom
Pharmaceuticals
biopharmaceutical services
Completed
Synopsis
Chiltern, a private equity firm, completed the investment in Centaur Healthcare, a contract development manufacturing organisation predominantly servicing the pharmaceutical market, with participation from Souter Investments and Bluester Capital. Financial terms were not disclosed. “Through our research and direct origination team, we had been targeting a platform investment in the pharmaceutical sector and Surepharm gives us a strong market entry point. We have built an ambitious management team of sector experts, and are looking forward to delivering the plan through a combination of organic investment and complementary M&A," Joe Bennett, Chiltern Capital Partner.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.